| Detected | Trial | Change |
|---|---|---|
| 2026-05-27 | NCT07079475 Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have… |
Enrollment reduced: 200 -> 160 participants |
| 2026-05-27 | NCT07079475 Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have… |
Trial sites expanded: 7 -> 17 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05668988 | A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT06563999 | Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare… | Lung Cancer Stage III | Recruiting |
| Phase 1/2 | |||
| NCT06195189 | Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase… | Non Small Cell Lung Cancer | Recruiting |
| NCT07079475 | Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have… | Non-Small Cell Lung Cancer | Recruiting |
| NCT03974022 | Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT06905197 | A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have… | Non Small Cell Lung Cancer | Recruiting |